Connect to other sites within the UBM Medica Network
J&J’s Ethicon Initiates Worldwide Withdrawal of Morcellators
The morcellation controversy heats up as physicians all over the world who use Ethicon power morcellators are being asked to return the medical devices.
Morcellation: Doctors Need Data, Not Rhetoric
Gyns morcellate fibroids because it benefits patients, not their wallet. Despite the risks, the procedure has a place in treatment, until data say otherwise.
The Decline of the Preferred Approach to Hysterectomy
Vaginal hysterectomies are associated with superior patient outcomes and cost less than other methods of hysterectomy. So why is their rate of use declining?
FDA Examining Safety of Morcellators for Hysterectomy and Myomectomy
The FDA has weighed in on the safety of uterine fibroid morcellation. Given the current evidence, find out what they recommend.
Hysterectomy for Fibroids Among the Top 4 Surgeries to Avoid
Patients with uterine fibroids have been advised to avoid a hysterectomy as treatment of the condition at all costs. Sound advice or mucky water?
Are Angiogenic Growth Factors the Future of Fibroid Therapy?
Evidence indicates that angiogenic growth factors have an important role in fibroid pathophysiology, including abnormal vasculature and fibroid growth and survival.
Robotic, Abdominal Myomectomy Equally Effective
Robotic-assisted laparoscopic myomectomy and abdominal myomectomy to manage uterine fibroids were equally effective in improving symptoms, but each procedure has its own benefits.
VIDEO: Myosure Resection of Fibroid
This surgical video shows resection of a 3-cm intracavity fibroid using minimally invasive surgical technology. The patient, a 40-year-old woman, presented with a 60-day history of abnormal bleeding.
VIDEO: Laparoscopic Removal of Intracavitary Uterine Fibroid
This procedure was performed to remove an intracavitary fibroid that failed hysteroscopy on two occasions.
By clicking Accept, you agree to become a member of the UBM Medica Community.